Atlas Trials

Molecular Partners AG

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Molecular Partners AG

RecordFirmDate
Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors (NCT07278479)Molecular Partners AG2026-05-18
Study of MP0533 in Patients Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT05673057)Molecular Partners AG2022-12-29
First-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid Tumors (NCT05098405)Molecular Partners AG2021-10-11
Viral Clearance, PK and Tolerability of Ensovibep in COVID-19 Patients (NCT04834856)Molecular Partners AG2021-04-01
Safety, Tolerability and PK of Ensovibep (MP0420 - a New Candidate With Potential for Treatment of COVID-19) (NCT04870164)Molecular Partners AG2020-11-18
Study to Investigate the Safety, Blood Levels and Activity of MP0310 in Patients With Advanced Solid Tumors (NCT04049903)Molecular Partners AG2019-09-02
MP0250 DARPin® Protein Plus Osimertinib in Patients With EGFR-mutated NSCLC (NCT03418532)Molecular Partners AG2018-03-22

Track Molecular Partners AG automatically

Every clearance here is in the API, with alerts when new ones post.